Cargando…

[Retracted] Isoquercitrin inhibits the progression of liver cancer in vivo and in vitro via the MAPK signalling pathway

Detalles Bibliográficos
Autores principales: Huang, Guihong, Tang, Bo, Tang, Kun, Dong, Xiaomin, Deng, Jungang, Liao, Luqin, Liao, Zengzhen, Yang, Hua, He, Songqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018447/
https://www.ncbi.nlm.nih.gov/pubmed/36866771
http://dx.doi.org/10.3892/or.2023.8510
_version_ 1784907810265366528
author Huang, Guihong
Tang, Bo
Tang, Kun
Dong, Xiaomin
Deng, Jungang
Liao, Luqin
Liao, Zengzhen
Yang, Hua
He, Songqing
author_facet Huang, Guihong
Tang, Bo
Tang, Kun
Dong, Xiaomin
Deng, Jungang
Liao, Luqin
Liao, Zengzhen
Yang, Hua
He, Songqing
author_sort Huang, Guihong
collection PubMed
description
format Online
Article
Text
id pubmed-10018447
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-100184472023-03-17 [Retracted] Isoquercitrin inhibits the progression of liver cancer in vivo and in vitro via the MAPK signalling pathway Huang, Guihong Tang, Bo Tang, Kun Dong, Xiaomin Deng, Jungang Liao, Luqin Liao, Zengzhen Yang, Hua He, Songqing Oncol Rep Retraction D.A. Spandidos 2023-02-28 /pmc/articles/PMC10018447/ /pubmed/36866771 http://dx.doi.org/10.3892/or.2023.8510 Text en Copyright: © Huang et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.
spellingShingle Retraction
Huang, Guihong
Tang, Bo
Tang, Kun
Dong, Xiaomin
Deng, Jungang
Liao, Luqin
Liao, Zengzhen
Yang, Hua
He, Songqing
[Retracted] Isoquercitrin inhibits the progression of liver cancer in vivo and in vitro via the MAPK signalling pathway
title [Retracted] Isoquercitrin inhibits the progression of liver cancer in vivo and in vitro via the MAPK signalling pathway
title_full [Retracted] Isoquercitrin inhibits the progression of liver cancer in vivo and in vitro via the MAPK signalling pathway
title_fullStr [Retracted] Isoquercitrin inhibits the progression of liver cancer in vivo and in vitro via the MAPK signalling pathway
title_full_unstemmed [Retracted] Isoquercitrin inhibits the progression of liver cancer in vivo and in vitro via the MAPK signalling pathway
title_short [Retracted] Isoquercitrin inhibits the progression of liver cancer in vivo and in vitro via the MAPK signalling pathway
title_sort [retracted] isoquercitrin inhibits the progression of liver cancer in vivo and in vitro via the mapk signalling pathway
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018447/
https://www.ncbi.nlm.nih.gov/pubmed/36866771
http://dx.doi.org/10.3892/or.2023.8510
work_keys_str_mv AT huangguihong retractedisoquercitrininhibitstheprogressionoflivercancerinvivoandinvitroviathemapksignallingpathway
AT tangbo retractedisoquercitrininhibitstheprogressionoflivercancerinvivoandinvitroviathemapksignallingpathway
AT tangkun retractedisoquercitrininhibitstheprogressionoflivercancerinvivoandinvitroviathemapksignallingpathway
AT dongxiaomin retractedisoquercitrininhibitstheprogressionoflivercancerinvivoandinvitroviathemapksignallingpathway
AT dengjungang retractedisoquercitrininhibitstheprogressionoflivercancerinvivoandinvitroviathemapksignallingpathway
AT liaoluqin retractedisoquercitrininhibitstheprogressionoflivercancerinvivoandinvitroviathemapksignallingpathway
AT liaozengzhen retractedisoquercitrininhibitstheprogressionoflivercancerinvivoandinvitroviathemapksignallingpathway
AT yanghua retractedisoquercitrininhibitstheprogressionoflivercancerinvivoandinvitroviathemapksignallingpathway
AT hesongqing retractedisoquercitrininhibitstheprogressionoflivercancerinvivoandinvitroviathemapksignallingpathway